Jones ML - Search Results

1

Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.

Alfaleh MA, Howard CB, Sedliarou I, Jones ML, Gudhka R, Vanegas N, Weiss J, Suurbach JH, de Bakker CJ, Milne MR, Rumballe BA, MacDiarmid JA, Brahmbhatt H, Mahler SM. Alfaleh MA, et al. Among authors: jones ml. PLoS One. 2017 Oct 23;12(10):e0186137. doi: 10.1371/journal.pone.0186137. eCollection 2017. PLoS One. 2017. PMID: 29059207 Free PMC article.

2

A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies.

Jones ML, Seldon T, Smede M, Linville A, Chin DY, Barnard R, Mahler SM, Munster D, Hart D, Gray PP, Munro TP. Jones ML, et al. J Immunol Methods. 2010 Mar 31;354(1-2):85-90. doi: 10.1016/j.jim.2010.02.001. Epub 2010 Feb 11. J Immunol Methods. 2010. PMID: 20153332

3

Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2.

Leow CH, Jones M, Cheng Q, Mahler S, McCarthy J. Leow CH, et al. Malar J. 2014 Jul 18;13:277. doi: 10.1186/1475-2875-13-277. Malar J. 2014. PMID: 25037150 Free PMC article.

4

Nanocell targeting using engineered bispecific antibodies.

Taylor K, Howard CB, Jones ML, Sedliarou I, MacDiarmid J, Brahmbhatt H, Munro TP, Mahler SM. Taylor K, et al. Among authors: jones ml. MAbs. 2015;7(1):53-65. doi: 10.4161/19420862.2014.985952. MAbs. 2015. PMID: 25523746 Free PMC article.

5

Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.

Seldon TA, Pryor R, Palkova A, Jones ML, Verma ND, Findova M, Braet K, Sheng Y, Fan Y, Zhou EY, Marks JD, Munro T, Mahler SM, Barnard RT, Fromm PD, Silveira PA, Elgundi Z, Ju X, Clark GJ, Bradstock KF, Munster DJ, Hart DN. Seldon TA, et al. Among authors: jones ml. Leukemia. 2016 Mar;30(3):692-700. doi: 10.1038/leu.2015.231. Epub 2015 Aug 19. Leukemia. 2016. PMID: 26286117

6

Biosensing made easy with PEG-targeted bi-specific antibodies.

Raftery LJ, Grewal YS, Howard CB, Jones ML, Shiddiky MJ, Carrascosa LG, Thurecht KJ, Mahler SM, Trau M. Raftery LJ, et al. Among authors: jones ml. Chem Commun (Camb). 2016 Apr 28;52(33):5730-3. doi: 10.1039/c6cc01916a. Chem Commun (Camb). 2016. PMID: 27045479

7

Targeting membrane proteins for antibody discovery using phage display.

Jones ML, Alfaleh MA, Kumble S, Zhang S, Osborne GW, Yeh M, Arora N, Hou JJ, Howard CB, Chin DY, Mahler SM. Jones ML, et al. Sci Rep. 2016 May 18;6:26240. doi: 10.1038/srep26240. Sci Rep. 2016. PMID: 27189586 Free PMC article.

8

Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.

Howard CB, Fletcher N, Houston ZH, Fuchs AV, Boase NR, Simpson JD, Raftery LJ, Ruder T, Jones ML, de Bakker CJ, Mahler SM, Thurecht KJ. Howard CB, et al. Among authors: jones ml. Adv Healthc Mater. 2016 Aug;5(16):2055-68. doi: 10.1002/adhm.201600263. Epub 2016 Jun 10. Adv Healthc Mater. 2016. PMID: 27283923

9

Beyond Antibodies: Development of a Novel Protein Scaffold Based on Human Chaperonin 10.

Alsultan AM, Chin DY, Howard CB, de Bakker CJ, Jones ML, Mahler SM. Alsultan AM, et al. Among authors: jones ml. Sci Rep. 2016 Nov 22;5:37348. doi: 10.1038/srep37348. Sci Rep. 2016. PMID: 27874025 Free PMC article.

10

Biosimilars approved for treatment of inflammatory rheumatological diseases.

Mahler SM, Wardiana A, Jones ML, de Bakker CJ, Graham GG, Howard CB. Mahler SM, et al. Among authors: jones ml. Int J Rheum Dis. 2016 Nov;19(11):1043-1048. doi: 10.1111/1756-185X.13037. Int J Rheum Dis. 2016. PMID: 28032957 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

540 results

Search Page